Document:

Exhibit
10.83 

 

NEITHER
THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR
TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THIS SECURITY AND THE SECURITIES ISSUABLE UPON
EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

 

COMMON
STOCK PURCHASE WARRANT

 

CARBONMETA
TECHNOLOGIES, INC.

 

Warrant
Shares: 37,500,000

Date
of Issuance: September 12, 2022 (“Issuance Date”)

 

This
COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance
of the promissory note in the principal amount of $25,000 to the Holder (as defined below) of even date (the “Note”), RPG
Capital Partners Inc. (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms
and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof,
to purchase from CARBONMETA TECHNOLOGIES, INC., a Delaware corporation (the “Company”), 37,500,000 shares of Common
Stock (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions
of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection
with that certain securities purchase agreement dated September 12, 2022, by and among the Company and the Holder (the “Purchase
Agreement”).

 

Capitalized
terms used in this Warrant shall have the meanings set forth in the Purchase Agreement unless otherwise defined in the body of this Warrant
or in Section 12 below. For purposes of this Warrant, the term “Exercise Price” shall mean $0.0004, subject to adjustment
as provided herein (including but not limited to cashless exercise), and the term “Exercise Period” shall mean the period
commencing on the Issuance Date and ending on 5:00 p.m. eastern standard time on the five-year anniversary thereof.

 

1.
EXERCISE OF WARRANT.

 

(a)
Mechanics of Exercise. Subject to the terms and conditions hereof, the rights represented by this Warrant may be exercised in
whole or in part at any time or times during the Exercise Period by delivery of a written notice, in the form attached hereto as Exhibit
A (the “Exercise Notice”), of the Holder’s election to exercise this Warrant. The Holder shall not be required
to deliver the original Warrant in order to effect an exercise hereunder. Partial exercises of this Warrant resulting in purchases of
a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant
Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. On or before the second Trading
Day (the “Warrant Share Delivery Date”) following the date on which the Holder sent the Exercise Notice to the Company
or the Company’s transfer agent, and upon receipt by the Company of payment to the Company of an amount equal to the applicable
Exercise Price multiplied by the number of Warrant Shares as to which all or a portion of this Warrant is being exercised (the “Aggregate
Exercise Price” and together with the Exercise Notice, the “Exercise Delivery Documents”) in cash or by
wire transfer of immediately available funds (or by cashless exercise, in which case there shall be no Aggregate Exercise Price provided),
the Company shall (or direct its transfer agent to) issue and deliver by overnight courier to the address as specified in the Exercise
Notice, a certificate, registered in the Company’s share register in the name of the Holder or its designee, for the number of
shares of Common Stock to which the Holder is entitled pursuant to such exercise (or deliver such shares of Common Stock in electronic
format if requested by the Holder). Upon delivery of the Exercise Delivery Documents, the Holder shall be deemed for all corporate purposes
to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the
date of delivery of the certificates evidencing such Warrant Shares. If this Warrant is submitted in connection with any exercise and
the number of Warrant Shares represented by this Warrant submitted for exercise is greater than the number of Warrant Shares being acquired
upon an exercise, then the Company shall as soon as practicable and in no event later than three business days after any exercise and
at its own expense, issue a new Warrant (in accordance with Section 6) representing the right to purchase the number of Warrant Shares
purchasable immediately prior to such exercise under this Warrant, less the number of Warrant Shares with respect to which this Warrant
is exercised.

 

    	1

     

    

 

If
the Company fails to cause its transfer agent to issue to the Holder the respective shares of Common Stock by the respective Warrant
Share Delivery Date, then the Holder will have the right to rescind such exercise in Holder’s sole discretion in addition to all
other rights and remedies at law, under this Warrant, or otherwise, and such failure shall also be deemed an event of default under the
Note, a material breach under this Warrant, and a material breach under the Purchase Agreement.

 

If
the Market Price of one share of Common Stock is greater than the Exercise Price, then the Holder may elect to receive Warrant Shares
pursuant to a cashless exercise, in lieu of a cash exercise, equal to the value of this Warrant determined in the manner described below
(or of any portion thereof remaining unexercised) by surrender of this Warrant and an Exercise Notice, in which event the Company shall
issue to Holder a number of Common Stock computed using the following formula:

 

	 	X	=
  Y (A-B)	 
	 	 	A	 

 

	 	Where
    	X
    	=	the
    number of Shares to be issued to Holder.
	 	 	 	 	 
	 	 	Y
    	=	the
    number of Warrant Shares that the Holder elects to purchase under this Warrant (at the date of such calculation).
	 	 	 	 	 
	 	 	A
    	=	the
    Market Price (at the date of such calculation).
	 	 	 	 	 
	 	 	B
    	=	Exercise
    Price (as adjusted to the date of such calculation).

 

(b)
No Fractional Shares. No fractional shares shall be issued upon the exercise of this Warrant as a consequence of any adjustment
pursuant hereto. All Warrant Shares (including fractions) issuable upon exercise of this Warrant may be aggregated for purposes of determining
whether the exercise would result in the issuance of any fractional share. If, after aggregation, the exercise would result in the issuance
of a fractional share, the Company shall, in lieu of issuance of any fractional share, pay the Holder otherwise entitled to such fraction
a sum in cash equal to the product resulting from multiplying the then-current fair market value of a Warrant Share by such fraction.

 

    	2

     

    

 

(c)
Holder’s Exercise Limitations. Notwithstanding anything to the contrary contained herein, the Company shall not effect any
exercise of this Warrant, and a Holder shall not have the right to exercise any portion of this Warrant, pursuant to Section 1 or otherwise,
to the extent that after giving effect to such issuance after exercise as set forth on the applicable Exercise Notice, the Holder (together
with the Holder’s affiliates (the “Affiliates”), and any other Persons acting as a group together with the Holder or
any of the Holder’s Affiliates (such Persons, “Attribution Parties”)), would beneficially own in excess of the Beneficial
Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned
by the Holder and Attribution Parties shall include the number of shares of Common Stock issuable upon exercise of this Warrant with
respect to which such determination is being made, but shall exclude the number of shares of Common Stock which would be issuable upon
(i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution
Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including,
without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation
contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding
sentence, for purposes of this Section 1(c), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange
Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Holder is solely responsible for
any schedules required to be filed in accordance therewith. In addition, a determination as to any group status as contemplated above
shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes
of this Section 1(c), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding
shares of Common Stock as reflected in (A) the Company’s most recent periodic or annual report filed with the Commission, as the
case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Company’s
transfer agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company
shall within two Trading Days confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any
case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities
of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number
of outstanding shares of Common Stock was reported. The “Beneficial Ownership Limitation” shall be 4.99% of the number of
shares of the Common Stock outstanding at the time of the respective calculation hereunder. The limitations contained in this paragraph
shall apply to a successor holder of this Warrant.

 

(d)
Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise. In addition to any other rights available to
the Holder, if the Company fails to cause the Company’s transfer agent to transmit to the Holder the Warrant Shares in accordance
with the provisions of this Warrant (including but not limited to Section 1(a) above pursuant to an exercise on or before the respective
Warrant Share Delivery Date, and if after such date the Holder is required by its broker to purchase (in an open market transaction or
otherwise) or the Holder’s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the
Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a “Buy-In”), then the Company shall
(A) pay in cash to the Holder, within one (1) business day of Holder’s request, the amount, if any, by which (x) the Holder’s
total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the product of
(1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times
(2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either
reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such
exercise shall be deemed rescinded) or deliver to the Holder within one (1) business day of Holder’s request the number of shares
of Common Stock that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For
example, if the Holder purchases, or effectuates a cashless exercise hereunder for, Common Stock having a total purchase price of $11,000
to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving rise to such purchase
obligation of $10,000, under clause (A) of the immediately preceding sentence, the Company shall be required to pay the Holder $1,000.
The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request
of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder’s right to pursue any other remedies available
to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect
to the Company’s failure to timely deliver shares of Common Stock upon exercise of the Warrant as required pursuant to the terms
hereof.

 

    	3

     

    

 

2.
ADJUSTMENTS. The Exercise Price and the number of Warrant Shares shall be adjusted from time to time as follows:

 

(a)
Distribution of Assets. If the Company shall declare or make any dividend or other distribution of its assets (or rights to acquire
its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including without limitation any distribution
of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement or
other similar transaction) (a “Distribution”), at any time after the issuance of this Warrant, then, in each such
case:

 

(i)
any Exercise Price in effect immediately prior to the close of business on the record date fixed for the determination of holders of
shares of Common Stock entitled to receive the Distribution shall be reduced, effective as of the close of business on such record date,
to a price determined by multiplying such Exercise Price by a fraction (i) the numerator of which shall be the Closing Sale Price of
the shares of Common Stock on the Trading Day immediately preceding such record date minus the value of the Distribution (as determined
in good faith by the Company’s Board of Directors) applicable to one share of Common Stock, and (ii) the denominator of which shall
be the Closing Sale Price of the shares of Common Stock on the Trading Day immediately preceding such record date; and

 

(ii)
the number of Warrant Shares shall be increased to a number of shares equal to the number of shares of Common Stock obtainable immediately
prior to the close of business on the record date fixed for the determination of holders of shares of Common Stock entitled to receive
the Distribution multiplied by the reciprocal of the fraction set forth in the immediately preceding clause (i); provided, however, that
in the event that the Distribution is of shares of common stock of a company (other than the Company) whose common stock is traded on
a national securities exchange or a national automated quotation system (“Other Shares of Common Stock”), then the
Holder may elect to receive a warrant to purchase Other Shares of Common Stock in lieu of an increase in the number of Warrant Shares,
the terms of which shall be identical to those of this Warrant, except that such warrant shall be exercisable into the number of shares
of Other Shares of Common Stock that would have been payable to the Holder pursuant to the Distribution had the Holder exercised this
Warrant immediately prior to such record date and with an aggregate exercise price equal to the product of the amount by which the exercise
price of this Warrant was decreased with respect to the Distribution pursuant to the terms of the immediately preceding clause (i) and
the number of Warrant Shares calculated in accordance with the first part of this clause (ii).

 

(b)
Anti-Dilution Adjustments to Exercise Price. If the Company or any Subsidiary thereof, as applicable, at any time while this Warrant
is outstanding, shall sell or grant any option to purchase, or sell or grant any right to reprice, or otherwise dispose of or issue (or
announce any offer, sale, grant or any option to purchase or other disposition) any Common Stock or securities entitling any person or
entity to acquire shares of Common Stock (upon conversion, exercise or otherwise) (including but not limited to the price at which Common
Stock is issuable under the Note), at an effective price per share less than the then Exercise Price (such lower price, the “Base
Share Price” and such issuances collectively, a “Dilutive Issuance”) (if the holder of the Common Stock or Common Stock
Equivalents so issued shall at any time, whether by operation of purchase price adjustments, elimination of an applicable floor price
for any reason in the future (including but not limited to the passage of time or satisfaction of certain condition(s)), reset provisions,
floating conversion, exercise or exchange prices or otherwise, or due to warrants, options or rights per share which are issued in connection
with such issuance, be entitled or potentially entitled to receive shares of Common Stock at an effective price per share which is less
than the Exercise Price at any time while such Common Stock or Common Stock Equivalents are in existence, such issuance shall be deemed
to have occurred for less than the Exercise Price on such date of the Dilutive Issuance (regardless of whether the Common Stock or Common
Stock Equivalents are (i) subsequently redeemed or retired by the Company after the date of the Dilutive Issuance or (ii) actually converted
or exercised at such Base Share Price), then the Exercise Price shall be reduced at the option of the Holder and only reduced to equal
the Base Share Price. Such adjustment shall be made whenever such Common Stock or Common Stock Equivalents are issued, regardless of
whether the Common Stock or Common Stock Equivalents are (i) subsequently redeemed or retired by the Company after the date of the Dilutive
Issuance or (ii) actually converted or exercised at such Base Share Price by the holder thereof (for the avoidance of doubt, the Holder
may utilize the Base Share Price even if the Company did not actually issue shares of its common stock at the Base Share Price under
the respective Common stock Equivalents). The Company shall notify the Holder in writing, no later than the Trading Day following the
issuance of any Common Stock or Common Stock Equivalents subject to this Section 2(b), indicating therein the applicable issuance price,
or applicable reset price, exchange price, conversion price and other pricing terms (such notice the “Dilutive Issuance Notice”).
For purposes of clarification, regardless of whether (i) the Company provides a Dilutive Issuance Notice pursuant to this Section 2(b)
upon the occurrence of any Dilutive Issuance or (ii) the Holder accurately refers to the Base Share Price in the Exercise Notice, the
Holder is entitled to utilize the Base Share Price at all times on and after the date of such Dilutive Issuance.

 

    	4

     

    

 

(c)
Subdivision or Combination of Common Stock. If the Company at any time on or after the Issuance Date subdivides (by any stock
split, stock dividend, recapitalization or otherwise) one or more classes of its outstanding shares of Common Stock into a greater number
of shares, the Exercise Price in effect immediately prior to such subdivision will be proportionately reduced and the number of Warrant
Shares will be proportionately increased. If the Company at any time on or after the Issuance Date combines (by combination, reverse
stock split or otherwise) one or more classes of its outstanding shares of Common Stock into a smaller number of shares, the Exercise
Price in effect immediately prior to such combination will be proportionately increased and the number of Warrant Shares will be proportionately
decreased. Any adjustment under this Section 2(c) shall become effective at the close of business on the date the subdivision or combination
becomes effective. Each such adjustment of the Exercise Price shall be calculated to the nearest one-hundredth of a cent. Such adjustment
shall be made successively whenever any event covered by this Section 2(c) shall occur.

 

3.
FUNDAMENTAL TRANSACTIONS. If, at any time while this Warrant is outstanding, (i) the Company effects any merger of the Company
with or into another entity and the Company is not the surviving entity (such surviving entity, the “Successor Entity”),
(ii) the Company effects any sale of all or substantially all of its assets in one or a series of related transactions, (iii) any tender
offer or exchange offer (whether by the Company or by another individual or entity, and approved by the Company) is completed pursuant
to which holders of Common Stock are permitted to tender or exchange their shares of Common Stock for other securities, cash or property
and the holders of at least 50% of the Common Stock accept such offer, or (iv) the Company effects any reclassification of the Common
Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities,
cash or property (other than as a result of a subdivision or combination of shares of Common Stock) (in any such case, a “Fundamental
Transaction”), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive the number of
shares of Common Stock of the Successor Entity or of the Company and any additional consideration (the “Alternate Consideration”)
receivable upon or as a result of such reorganization, reclassification, merger, consolidation or disposition of assets by a holder of
the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such event (disregarding any limitation
on exercise contained herein solely for the purpose of such determination). For purposes of any such exercise, the determination of the
Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration
issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price
among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration.
If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then
the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such
Fundamental Transaction. To the extent necessary to effectuate the foregoing provisions, any Successor Entity in such Fundamental Transaction
shall issue to the Holder a new warrant consistent with the foregoing provisions and evidencing the Holder’s right to exercise
such warrant into Alternate Consideration.

 

4.
NON-CIRCUMVENTION. The Company covenants and agrees that it will not, by amendment of its certificate of incorporation, bylaws
or through any reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issue or sale of securities,
or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, and will at
all times in good faith carry out all the provisions of this Warrant and take all action as may be required to protect the rights of
the Holder. Without limiting the generality of the foregoing, the Company (i) shall not increase the par value of any shares of Common
Stock receivable upon the exercise of this Warrant above the Exercise Price then in effect, (ii) shall take all such actions as may be
necessary or appropriate in order that the Company may validly and legally issue fully paid and non-assessable shares of Common Stock
upon the exercise of this Warrant, and (iii) shall, for so long as this Warrant is outstanding, have authorized and reserved, free from
preemptive rights, one and a half (1.5) times the number of shares of Common Stock into which the Warrants are then exercisable into
to provide for the exercise of the rights represented by this Warrant (without regard to any limitations on exercise).

 

    	5

     

    

 

5.
WARRANT HOLDER NOT DEEMED A STOCKHOLDER. Except as otherwise specifically provided herein, this Warrant, in and of itself, shall
not entitle the Holder to any voting rights or other rights as a stockholder of the Company. In addition, nothing contained in this Warrant
shall be construed as imposing any liabilities on the Holder to purchase any securities (upon exercise of this Warrant or otherwise)
or as a stockholder of the Company, whether such liabilities are asserted by the Company or by creditors of the Company.

 

6.
REISSUANCE.

 

(a)
Lost, Stolen or Mutilated Warrant. If this Warrant is lost, stolen, mutilated or destroyed, the Company will, on such terms as
to indemnity or otherwise as it may reasonably impose (which shall, in the case of a mutilated Warrant, include the surrender thereof),
issue a new Warrant of like denomination and tenor as this Warrant so lost, stolen, mutilated or destroyed.

 

(b)
Issuance of New Warrants. Whenever the Company is required to issue a new Warrant pursuant to the terms of this Warrant, such
new Warrant shall be of like tenor with this Warrant, and shall have an issuance date, as indicated on the face of such new Warrant which
is the same as the Issuance Date.

 

7.
TRANSFER. This Warrant shall be binding upon the Company and its successors and assigns, and shall inure to be the benefit of
the Holder and its successors and assigns. Notwithstanding anything to the contrary herein, the rights, interests or obligations of the
Company hereunder may not be assigned, by operation of law or otherwise, in whole or in part, by the Company without the prior signed
written consent of the Holder, which consent may be withheld at the sole discretion of the Holder (any such assignment or transfer shall
be null and void if the Company does not obtain the prior signed written consent of the Holder). This Warrant or any of the severable
rights and obligations inuring to the benefit of or to be performed by Holder hereunder may be assigned by Holder to a third party, in
whole or in part, without the need to obtain the Company’s consent thereto.

 

8.
NOTICES. Whenever notice is required to be given under this Warrant, unless otherwise provided herein, such notice shall be given
in accordance with the notice provisions contained in the Purchase Agreement. The Company shall provide the Holder with prompt written
notice (i) immediately upon any adjustment of the Exercise Price, setting forth in reasonable detail, the calculation of such adjustment
and (ii) at least 20 days prior to the date on which the Company closes its books or takes a record (A) with respect to any dividend
or distribution upon the shares of Common Stock, (B) with respect to any grants, issuances or sales of any stock or other securities
directly or indirectly convertible into or exercisable or exchangeable for shares of Common Stock or other property, pro rata to the
holders of shares of Common Stock or (C) for determining rights to vote with respect to any Fundamental Transaction, dissolution or liquidation,
provided in each case that such information shall be made known to the public prior to or in conjunction with such notice being provided
to the Holder.

 

9.
AMENDMENT AND WAIVER. The terms of this Warrant may be amended or waived (either generally or in a particular instance and either
retroactively or prospectively) only with the written consent of the Company and the Holder.

 

    	6

     

    

 

10.
GOVERNING LAW AND VENUE. This Warrant shall be governed by and construed in accordance with the laws of the State of Delaware
without regard to principles of conflicts of laws. Any action brought by either party against the other concerning the transactions contemplated
by this Warrant shall be brought only in the Court of Chancery of the State of Delaware or, to the extent such court does not have subject
matter jurisdiction, the United States District Court for the District of Delaware or, to the extent that neither of the foregoing courts
has jurisdiction, the Superior Court of the State of Delaware. The parties to this Warrant hereby irrevocably waive any objection to
jurisdiction and venue of any action instituted hereunder and shall not assert any defense based on lack of jurisdiction or venue or
based upon forum non conveniens. EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST,
A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR UNDER ANY OTHER TRANSACTION DOCUMENT ENTERED INTO IN CONNECTION WITH OR
ARISING OUT OF THIS WARRANT, OR ANY TRANSACTION CONTEMPLATED HEREBY OR THEREBY. The prevailing party shall be entitled to recover
from the other party its reasonable attorney’s fees and costs. In the event that any provision of this Warrant or any other agreement
delivered in connection herewith is invalid or unenforceable under any applicable statute or rule of law, then such provision shall be
deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to conform with such statute or rule of
law. Any such provision which may prove invalid or unenforceable under any law shall not affect the validity or enforceability of any
other provision of any agreement. Each party hereby irrevocably waives personal service of process and consents to process being served
in any suit, action or proceeding in connection with this Warrant or any other transaction document entered into in connection with this
Warrant by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at
the address in effect for notices to it under the Purchase Agreement and agrees that such service shall constitute good and sufficient
service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any
other manner permitted by law.

 

11.
ACCEPTANCE. Receipt of this Warrant by the Holder shall constitute acceptance of and agreement to all of the terms and conditions
contained herein.

 

12.
CERTAIN DEFINITIONS. For purposes of this Warrant, the following terms shall have the following meanings:

 

(a)
“Nasdaq” means www.Nasdaq.com.

 

(b)
“Closing Sale Price” means, for any security as of any date, (i) the last closing trade price for such security on
the Principal Market, as reported by Nasdaq, or, if the Principal Market begins to operate on an extended hours basis and does not designate
the closing trade price, then the last trade price of such security prior to 4:00 p.m., New York time, as reported by Nasdaq, or (ii)
if the foregoing does not apply, the last trade price of such security in the over-the-counter market for such security as reported by
Nasdaq, or (iii) if no last trade price is reported for such security by Nasdaq, the average of the bid and ask prices of any market
makers for such security as reported by the OTC Markets. If the Closing Sale Price cannot be calculated for a security on a particular
date on any of the foregoing bases, the Closing Sale Price of such security on such date shall be the fair market value as mutually determined
by the Company and the Holder. All such determinations to be appropriately adjusted for any stock dividend, stock split, stock combination
or other similar transaction during the applicable calculation period.

 

(c)
“Common Stock” means the Company’s common stock, par value $0.0001, and any other class of securities into which
such securities may hereafter be reclassified or changed.

 

(d)
“Common Stock Equivalents” means any securities of the Company that would entitle the holder thereof to acquire at
any time Common Stock, including without limitation any debt, preferred stock, rights, options, warrants or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.

 

(e)
[Intentionally Omitted].

 

(f)
“Person” and “Persons” means an individual, a limited liability company, a partnership, a joint
venture, a corporation, a trust, an unincorporated organization, any other entity and any governmental entity or any department or agency
thereof.

 

(g)
“Principal Market” means the principal securities exchange or trading market where such Common Stock is listed or
quoted, including but not limited to any tier of the OTC Markets, any tier of the NASDAQ Stock Market (including NASDAQ Capital Market),
or the NYSE American, or any successor to such markets.

 

(h)
“Market Price” means the highest traded price of the Common Stock during the one hundred and fifty Trading Days prior
to the date of the respective Exercise Notice.

 

(i)
“Trading Day” means any day on which the Common Stock is listed or quoted on its Principal Market, provided, however,
that if the Common Stock is not then listed or quoted on any Principal Market, then any calendar day.

 

* * * * * * *

 

    	7

     

    

 

IN
WITNESS WHEREOF, the Company has caused this Warrant to be duly executed as of the Issuance Date set forth above.

 

	 	CARBONMETA
    TECHNOLOGIES, INC.
	 	 	 
	 	
	 	Name:
    	Lloyd
    Spencer
	 	Title:
    	Chief
    Executive Officer

 

    	 

    	 

    

 

EXHIBIT
A

 

EXERCISE
NOTICE

 

(To
be executed by the registered holder to exercise this Common Stock Purchase Warrant)

 

THE
UNDERSIGNED holder hereby exercises the right to purchase ________________ of the shares of Common Stock (“Warrant
Shares”) of CARBONMETA TECHNOLOGIES, INC., a Delaware corporation (the “Company”), evidenced by the attached copy
of the Common Stock Purchase Warrant (the “Warrant”). Capitalized terms used herein and not otherwise defined shall have
the respective meanings set forth in the Warrant.

 

	1.	Form
    of Exercise Price. The Holder intends that payment of the Exercise Price shall be made as (check one):

 

		☐	a
                                            cash exercise with respect to _________________Warrant Shares; or
		☐	by
                                            cashless exercise pursuant to the Warrant.

 

	2.	Payment
    of Exercise Price. If cash exercise is selected above, the holder shall pay the applicable Aggregate Exercise Price in the sum
    of $_________________ to the Company in accordance with the terms of the Warrant.
	 	 
	3.	Delivery
    of Warrant Shares. The Company shall deliver to the holder ___________________ Warrant Shares in accordance with the terms of
    the Warrant.

 

	Date:
    	 	 	 	 
	 	 	 	 	 
	 	 	 	 
	 	 	 	(Print
    Name of Registered Holder)
	 	 	 	 	 
	 	 	 	By:	       
	 	 	 	Name:	 
	 	 	 	Title:
    	 

 

    	 

    	 

    

 

EXHIBIT
B

 

ASSIGNMENT
OF WARRANT

 

(To
be signed only upon authorized transfer of the Warrant)

 

FOR
VALUE RECEIVED, the undersigned hereby sells, assigns, and transfers unto __________________ the right to purchase
________________ shares of common stock of CARBONMETA TECHNOLOGIES, INC., to which the within Common Stock Purchase Warrant relates
and appoints ____, as attorney-in-fact, to transfer said right on the books of CARBONMETA TECHNOLOGIES, INC. with full power of
substitution and re-substitution in the premises. By accepting such transfer, the transferee has agreed to be bound in all respects
by the terms and conditions of the within Warrant.

 

	Dated:
    	 	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	(Signature)
    *
	 	 	 	 
	 	 	 	 
	 	 	 	(Name)
	 	 	 	 
	 	 	 	 
	 	 	 	(Address)
	 	 	 	 
	 	 	 	 
	 	 	 	(Social
    Security or Tax Identification No.)

 

*
The signature on this Assignment of Warrant must correspond to the name as written upon the face of the Common Stock Purchase Warrant
in every particular without alteration or enlargement or any change whatsoever. When signing on behalf of a corporation, partnership,
trust or other entity, please indicate your position(s) and title(s) with such entity.Exhibit
10.84

 

EMPLOYMENT
AGREEMENT

 

THIS
AGREEMENT (“Agreement”) is made and entered into this 15th day of May 2006 by and between Lloyd Spencer, a resident
of Redmond, Washington (the “Executive”) and Innova Holdings, Inc. (the “Corporation”), a Delaware
corporation with its principal place of business in Fort Myers, Florida. The Corporation has three wholly owned subsidiaries (each a
“Subsidiary” and together the “Subsidiaries”), namely, Robotic Workspace Technologies, Inc., CoroWare
Technologies, Inc. and Innova Robotics, Inc. Collectively, the Corporation and the Executive are referred to herein as the “Parties”
and sometimes individually as a “Party.”

 

R
E C I T A L S:

 

	 	A.	Executive
    has substantial experience which the Corporation believes valuable in its business and that of certain of its subsidiaries; and
	 	 	 
	 	B.	Corporation
    desires to employ the Executive as an executive of the Corporation and such of its Subsidiaries as the Chief Executive Officer deems
    appropriate and the Executive desires to accept such employment; and
	 	 	 
	 	C.	Corporation
    desires to appoint Executive to serve as a Director on its Subsidiaries’ Boards, and Executive desires to so serve.

 

NOW
THEREFORE, in consideration of the promises, mutual covenants and agreements contained herein, the Corporation and the Executive do hereby
agree as follows:

 

1.
Employment and Duties. On the terms and subject to the job conditions set forth in this Agreement, the Corporation shall employ
the Executive as an executive officer of the corporation and such of its Subsidiaries as it believes appropriate and to perform such
duties as are consistent with such position as may be assigned, from time to time, by the Chief Executive Officer of the Corporation
and to render such additional services and discharge such other responsibilities as the Corporation or designated Subsidiary may, from
time to time, stipulate, including without limitation serving as president of such designated Subsidiary. The costs of salary, expenses,
options, benefits and bonus related to all work performed for a Subsidiary shall be allocated to that Subsidiary.

 

2.
Performance. The Executive accepts the employment described in Paragraph 1 of this Agreement and agrees to devote all of
his business time and efforts to the faithful and diligent performance of the services described therein, including the performance of
such other services and responsibilities as the Corporation may, from time to time, stipulate.

 

    	1

    	 

    

 

3.
Term. The term (“Term”) of employment under this Agreement shall commence on May 15, 2006 (the “Commencement
Date”) and shall continue until the fifth anniversary date following the Commencement Date and shall be automatically renewable
for successive one year periods, unless terminated as provided herein. The Term of employment shall terminate:

 

a.
after three years from the Commencement Date, if either Party gives more than sixty days prior written notice to the other Party that
it wishes to terminate this Agreement; and

 

b.
immediately upon receipt of written notice for Just Cause or Good Reason.

 

For
purposes of this Agreement, the term “Just Cause” shall mean the occurrence of any one or more of the following events:
(i) the breach by the Executive of his covenants under this Agreement; (ii) the Executive’s refusal to perform, or his substantial
neglect of, the duties assigned to the Executive pursuant to Paragraph 1 hereof; (iii) the commission by the Executive of theft
or embezzlement of Corporation property or other acts of dishonesty; (iv) the commission by the Executive of a crime resulting in injury
to the business, property or reputation of the Corporation or any affiliate of the Corporation or commission of other significant activities
harmful to the business or reputation of the Corporation or any affiliate of the Corporation; (v) any significant violation of any statutory
or common law duty of loyalty to the Corporation; (vi) Executive’s neglect of his duties hereunder or his failure to devote the
time and attention to the Corporation’s business required herein; or (vii) Executive’s intentional violation of Corporation’s
rules, regulations, procedures or other policies.

 

For
purposes of this Agreement, the term “Good Reason” shall mean the occurrence of any one or more of the following events:
(i) the Corporation’s material breach of this Agreement; or (ii) a material change in Executive’s compensation and/or responsibilities
unless such change is agreed to in advance by Executive.

 

On
the effective date of termination of this Agreement for any reason, including, without limitation, the expiration of the Term, and regardless
of which Party effects the termination, the Executive shall return to the Corporation all Proprietary Information (as defined hereinafter),
and any other property belonging to the Corporation.

 

If
the Corporation terminates Executive’s employment without Just Cause or Executive terminates employment with Good Reason, Executive
shall be entitled to accrued but unpaid salary and benefits through the date of termination and shall receive a severance payment equal
to one-month’s current salary for each full year of employment, with a minimum severance payment of three (3) months and a maximum
of six (6) months’ pay; provided however, that Executive’s receipt of any severance payment shall be contingent on Executive
signing a separate agreement releasing all claims against the Corporation arising out of Executive’s employment. If Executive is
terminated for Just Cause or resigns without Good Reason, Executive shall be entitled only to salary and benefits accrued but unpaid
through the date of termination and shall receive no amount for severance.

 

    	2

    	 

    

 

If
Executive fails to give 90 days notice of termination without Good Reason, he shall forfeit 5,000 stock options for each day that he
fails to give notice, up to 450,000 options.

 

4.
Compensation.

 

a.
Salary. During the Term, the Corporation shall pay the Executive a salary in the amount of Twelve Thousand Five Hundred Dollars
($12,500) per month.

 

b.
Bonus. The Corporation’s Board of Directors retains the discretion to award to the Executive an annual bonus. The amount
of such bonus will be decided by the Board of Directors in its sole discretion..

 

c.
Stock Options. The Corporation. shall grant 5,000,000 stock options to Executive pursuant to the Corporation’s Stock Option
Plan at an exercise of $0.018 / share. All options shall vest annually from the grant date over a three year period and shall terminate
on the tenth anniversary of the date of grant, except that all unvested stock options shall vest immediately if the Corporation terminates
Executive’s employment without Just Cause, or Executive resigns for Good Reason

 

d.
Expenses. The Corporation shall pay Executive’s out of pocket expenses provided such expenses are within the Corporation’s
guidelines. The Executive shall provide the Corporation with an expense report and such substantiating documents as the Corporation requests
from time to time.

 

5.
Benefits. In addition to the reimbursement of the ordinary out of pocket business expenses described in 4.d, above, the Executive
shall be eligible for such other benefits as are offered to other executives in similar positions on such terms as the Corporation shall
determine in its sole discretion which as of the current date includes an executive medical program which includes dental and vision
coverage.

 

6.
Location. The Executive shall perform the duties required of him at the office of CoroWare Technologies, Inc. in the state of
Washington and such other locations as the Corporation may specify from time to time.

 

    	3

    	 

    

 

7.
Confidentiality of Information; Duty of Non-Disclosure.

 

c.
The Executive acknowledges and agrees that his employment by the Corporation under this Agreement necessarily involves his understanding
of and access to certain trade secrets and confidential information pertaining to the business of the Corporation. Accordingly, the Executive
agrees that at all times after the date of this Agreement he will not, directly or indirectly, without the express permission of the
Corporation, disclose to or use for the benefit of any person, corporation or other entity, or for himself any and all files, trade secrets
or other confidential information concerning the internal affairs of the Corporation, including, but not limited to, information pertaining
to its clients, services, products, earnings, finances, manufacturing, operations, suppliers, including without limitation its overseas
network of suppliers and other relations, methods, distribution system or other activities (“Proprietary Information”);
provided, however, that the foregoing shall not apply to information which is of public record or is generally known, disclosed or available
to the general public or the industry generally. Further, the Executive agrees that he shall not, directly or indirectly, remove or retain,
without the express prior written consent of the Corporation, and upon termination of this Agreement for any reason shall return to the
Corporation, any figures, calculations, letters, papers, records, computer disks, computer print-outs, lists, documents, instruments,
drawings, designs, programs, brochures, sales literature, or any copies thereof, or any information or instruments derived therefrom,
or any other similar information of any type or description, however such information might be obtained or recorded, arising out of or
in any way relating to the business of the Corporation or obtained as a result of his employment by the Corporation. The Executive acknowledges
that all of the foregoing are proprietary information, and are the exclusive property of the Corporation. The covenants contained in
this Paragraph 7 shall survive the termination of Executive’s employment or this Agreement.

 

8.
Covenant Not to Compete.

 

a.
During Employment Period. During the Term, the Executive shall not, without the prior written consent of the Corporation, engage
in any other business activity for gain, profit, or other pecuniary advantage (excepting the investment of funds in such form or manner
as will not require any services on the part of the Executive in the operation of the affairs of the companies in which such investments
are made) or engage in or in any manner be connected or concerned, directly or indirectly, whether as an officer, director, stockholder,
partner, owner, Executive, creditor, or otherwise, with the operation, management, or conduct of any business that competes with or is
of a nature similar to that of the Corporation.

 

    	4

    	 

    

 

b.
Following End of Term. 

 

	 	(i)	For
    the purposes of this sub-section, the term “Involved Subsidiary” shall include: (1) any subsidiary of the Corporation
    with which Executive was actually employed; (2) any subsidiary of the Corporation for which Executive served on the Board of Directors;
    and (3) any subsidiary of the Corporation that possesses confidential information or has customers to which Executive had direct
    access during his employment. 
	 	(ii)	Within
    the twelve (12) month period immediately following the termination of the Executive’s employment with the Corporation, regardless
    of the reason therefore, the Executive shall not, without the prior written consent of the Corporation, interfere with, or divert
    any customer served by any Involved Subsidiary, or any prospective customer identified by or on behalf of any Involved Subsidiary,
    or any supplier to any Involved Subsidiary who was a supplier or prospective supplier during the Executive’s employment with
    the Corporation, wherever located. 
	 	(iii)	In
    addition, during the twelve (12) month period immediately following the termination of the Executive’s employment with the
    Corporation, regardless of the reason therefore, the Executive shall not engage in or in any manner be connected or concerned, directly
    or indirectly, whether as an officer, director, stockholder, partner, owner, executive, creditor, or otherwise, with the operation,
    management, or conduct of any business that competes with or is of a nature similar to that of any Involved Subsidiary’s robotic
    activities and software systems integration activities without the prior written approval of the Corporation.
	 	(iv)	In
    addition, during the twenty four (24) month period immediately following the termination of the Executive’s employment with
    the Corporation, regardless of the reason therefore, the Executive shall not engage in or in any manner be connected or concerned
    with any business activity, either as an employee, owner, consultant or any other activity involving a product or technology that
    Executive had initiated, or actively participated in while employed by the Corporation.
	 	(v)	Executive
    has the right to seek employment with Microsoft at any time, but shall provide the Company with a minimum two (2) week notice of
    intent to leave.

 

    	5

    	 

    

 

	 	(v)	Executive
    has the right to seek an alternative employer if the Company reduces Executives compensation as it is detailed in this Agreement.
	 	(vi)	The
    term of this agreement will be modified if Executive terminates his employment to a ratio of total stock value of INRA compared to
    the annual salary; said ratio shall be used to adjust the total months of this non-compete, but the number of months cannot exceed
    the months identified herein above (ie., if the ratio is greater than 1 it shall not cause the term to exceed the 12 or 24 months
    specified herein).

 

The
covenants contained in this Paragraph 8 shall survive the termination of Executive’s employment under this Agreement.

 

9.
Severability. The Executive agrees and acknowledges that the Corporation does not have any adequate remedy at law for the breach
or threatened breach by the Executive of the covenants contained in Paragraphs 7 and 8 of this Agreement, and agrees that the
Corporation shall be entitled to injunctive relief to bar the Executive from such breach or threatened breach in addition to any other
remedies which may be available to the Corporation at law or in equity. The covenants of the Executive contained in Paragraphs 7 and
8 of this Agreement shall each be construed as an agreement independent of any other provision in this Agreement, and the existence
of any claim or cause of action of the Executive against the Corporation, whether predicated on this Agreement or otherwise, shall not
constitute a defense to the enforcement by the Corporation of such covenants. If any part of any covenant or other term of this Agreement
is determined by a court of law to be overly broad thereby making the covenant unenforceable, the parties hereto agree, and it is their
desire, that the court shall substitute a judicially enforceable limitation in its place, and that as so modified the covenant shall
be binding upon the parties as if originally set forth herein.

 

10.
Inventions, Designs, and Secrecy. Except as otherwise provided in this Section 10 , the Executive: (a) shall hold in a
fiduciary capacity for the benefit of the Corporation all secret or confidential information, knowledge, or data of the Corporation or
its business or production operations obtained by the Executive during his employment by the Corporation, which shall not be generally
known to the public or recognized as standard practice (whether or not developed by the Executive) and shall not, during his employment
by the Corporation and after the termination of such employment for any reason, communicate or divulge any such information, knowledge
or data to any person, firm or corporation other than the Corporation or persons, firms or corporations designated by the Corporation;
(b) shall promptly disclose to the Corporation all designs, inventions, software programs, ideas, devices, and processes made or conceived
by him alone or jointly with others, from the time of entering the Corporation’s employ until such employment is terminated, relevant
or pertinent in any way, whether directly or indirectly, to the Corporation’s business or production operations or resulting from
or suggested by any work which he may have done for the Corporation or at its request; (c) shall, at all times during employment with
the Corporation, assist the Corporation in every proper way (entirely at the Corporation’s expense) to obtain and develop for the
Corporation’s benefit patents or copyrights on such designs, software programs, inventions, ideas, devices and processes including
without limitation software code or software for use in the robotics industry, whether or not patented, trademarked, or copyrighted;
and (d) shall do all such acts and execute, acknowledge and deliver all such instruments as may be necessary or desirable in the opinion
of the Corporation to vest in the Corporation the entire interest in such designs, inventions, ideas, devices, and processes referred
to above. The foregoing to the contrary notwithstanding, the Executive shall not be required to assign or offer to assign to the Corporation
any of Executive’s rights in any design or invention for which no equipment, supplies, facility, or trade secret information of
the Corporation was used and which was developed entirely on the Executive’s own time, unless (a) the design or invention related
to (i) the business of the Corporation or (ii) the Corporation’s actual or demonstrably anticipated research or development, or
(b) the design, software or invention results from any work performed by the Executive for the Corporation. The Executive acknowledges
his prior receipt of written notification of the limitation set forth in the preceding sentence on the Executive’s obligation to
assign or offer to assign to the Corporation the Executive’s rights in designs and inventions.

 

    	6

    	 

    

 

11.
Notice. All notices, demands, instructions and other communications required or permitted to be given to or made upon either Party
hereto or any other person shall be in writing and shall be personally delivered or sent by registered or certified mail, postage prepaid,
return receipt requested (with a copy by facsimile, if such Party has provided a facsimile number), or by a reputable courier delivery
service, or by telegram (with messenger delivery), or by facsimile (confirmed by mail), and shall be deemed to be given for purposes
of this Agreement on the day that such writing is delivered or sent to the intended recipient thereof in accordance with the provisions
of this Paragraph. Unless otherwise specified in a notice sent or delivered in accordance with the foregoing provisions of this Paragraph,
notices, demands, instructions and other communications in writing shall be given to or made upon the respective Parties hereto at the
following address:

 

To
the Corporation:

 

Innova
Holdings, Inc.

1708
San Carlos Blvd., A6-151

Ft.
Myers, Florida 3

Attention:
Walter Weisel

Facsimile
No: (312) 427-6511

 

With
a copy to:

 

Linda
R. Robison

2659
West Gulf Drive, Unit B102

Sanibel,
FL 33957

Facsimile
Number: (888) 403-2412

 

To
the Executive:

 

Lloyd
Spencer

18529
NE 184th Street, Woodinville, WA 98077

 

Any
such notice shall be deemed effective on the fifth (5th) business day after its mailing.

 

12.
Transfer.

 

a.
The Corporation shall have the right in its discretion to freely assign or transfer its interests under this Agreement provided such
assignment or transfer is in connection with a sale of all or substantially all of its assets, if such assignee assumes all obligations
of the Corporation to the Executive arising under the provisions of this Agreement.

 

    	7

    	 

    

 

b.
This Agreement is personal to the Executive, and neither all nor any part of this Agreement directly or indirectly may be assigned or
transferred by the Executive without the Corporation’s prior written approval.

 

13.
Miscellaneous.

 

a.
Controlling Law. This Agreement shall be governed by and interpreted, construed and enforced in accordance with the laws of the
United States of America and the State of Florida. The Parties acknowledge and agree that any dispute resolution regarding the Executive’s
employment shall be adjudicated in any Federal court located in Fort Myers, Florida USA, unless otherwise mutually agreed by the parties.

 

b.
Entire Agreement. This instrument contains the entire agreement of the Parties with respect to its subject matter and may not
be changed orally but only by an Agreement in writing signed by the Parties hereto.

 

c.
Failure to Enforce. The failure of either Party to enforce any of the provisions of this Agreement shall not be construed as a
waiver of such provisions. Further, any express waiver of a breach of any provision hereunder by any Party shall not constitute a waiver
of any prior or subsequent breach or of such Party’s right to fully enforce thereafter each and every provision of this Agreement.

 

d.
Headings. All numbers and heading of paragraphs and subparagraphs in this Agreement are for convenience of reference only and
are not intended to qualify, limit or otherwise affect the meaning or interpretation of this Agreement.

 

    	8

    	 

    

 

WHEREFORE,
the Parties have executed this Agreement as of the date and year first above written.

 

	EXECUTIVE:	 	CORPORATION:
		 	 	 
	 	 	Innova
    Holdings, Inc.
	 	 	 	 
		 	By:	                        
	David
    Hyams 	 	Its:
    	

 

    	9

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00348-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00348-of-00352.parquet"}]]